Evidence map›Paper›PMID 35031037›Full record

ArticleBMC health services research2022

Cost of integrating assisted partner services in HIV testing services in Kisumu and Homa Bay counties, Kenya: a microcosting study.

Beatrice Wamuti, Monisha Sharma, Edward Kariithi, Harison Lagat, George Otieno, Rose Bosire, Sarah Masyuko, Mary Mugambi, Bryan J Weiner, David A Katz and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC health services research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Beatrice WamutiDepartment of Global Health, University of Washington, 325 9th Avenue, Box 359909, Seattle, WA, 98104, USA. bwamuti@uw.edu.
Monisha SharmaDepartment of Global Health, University of Washington, 325 9th Avenue, Box 359909, Seattle, WA, 98104, USA.
Edward KariithiPATH- Kenya, Kisumu, Kenya.
Harison LagatPATH- Kenya, Kisumu, Kenya.
George OtienoPATH- Kenya, Kisumu, Kenya.
Rose BosireKenya Medical Research Institute, Nairobi, Kenya.
Sarah MasyukoDepartment of Global Health, University of Washington, 325 9th Avenue, Box 359909, Seattle, WA, 98104, USA.
Mary MugambiMinistry of Health, Nairobi, Kenya.
Bryan J WeinerDepartment of Global Health, University of Washington, 325 9th Avenue, Box 359909, Seattle, WA, 98104, USA.
David A KatzDepartment of Global Health, University of Washington, 325 9th Avenue, Box 359909, Seattle, WA, 98104, USA.
Carey FarquharDepartment of Global Health, University of Washington, 325 9th Avenue, Box 359909, Seattle, WA, 98104, USA.
Carol LevinDepartment of Global Health, University of Washington, 325 9th Avenue, Box 359909, Seattle, WA, 98104, USA.
University of Washington · USMinistry of Health · KEKenya Medical Research Institute · KE

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
IMPLEMENTING ASSISTED PARTNER SERVICES TO HIV TEST AND TREAT MEN IN WESTERN KENYAR01AI134130 · NIAID · UNIVERSITY OF WASHINGTON · PI FARQUHAR, CAREY · 2017 to 2021
$3.6M
NIAID NIH HHS P30 AI027757NIAID NIH HHS R01 AI134130
6 · The paper itself

Abstract

backgroundHIV assisted partner services (aPS), or provider notification and testing for sexual and injecting partners of people diagnosed with HIV, is shown to be safe, effective, and cost-effective and was scaled up within the national HIV testing services (HTS) program in Kenya in 2016. We estimated the costs of integrating aPS into routine HTS within an ongoing aPS scale-up project in western Kenya.

methodsWe conducted microcosting using the payer perspective in 14 facilities offering aPS. Although aPS was offered to both males and females testing HIV-positive (index clients), we only collected data on female index clients and their male sex partners (MSP). We used activity-based costing to identify key aPS activities, inputs, resources, and estimated financial and economic costs of goods and services. We analyzed costs by start-up (August 2018), and recurrent costs one-year after aPS implementation (Kisumu: August 2019; Homa Bay: January 2020) and conducted time-and-motion observations of aPS activities. We estimated the incremental costs of aPS, average cost per MSP traced, tested, testing HIV-positive, and on antiretroviral therapy, cost shares, and costs disaggregated by facility.

resultsOverall, the number of MSPs traced, tested, testing HIV-positive, and on antiretroviral therapy was 1027, 869, 370, and 272 respectively. Average unit costs per MSP traced, tested, testing HIV-positive, and on antiretroviral therapy were $34.54, $42.50, $108.71 and $152.28, respectively, which varied by county and facility client volume. The weighted average incremental cost of integrating aPS was $7,485.97 per facility per year, with recurrent costs accounting for approximately 90% of costs. The largest cost drivers were personnel (49%) and transport (13%). Providers spent approximately 25% of the HTS visit obtaining MSP contact information (HIV-negative clients: 13 out of 54 min; HIV-positive clients: 20 out of 96 min), while the median time spent per MSP traced on phone and in-person was 6 min and 2.5 hours, respectively.

conclusionAverage facility costs will increase when integrating aPS to HTS with incremental costs largely driven by personnel and transport. Strategies to efficiently utilize healthcare personnel will be critical for effective, affordable, and sustainable aPS.

Indexed as

BaysHIV InfectionsCost-Benefit AnalysisFemaleHIV TestingHumansKenyaMaleSexual PartnersAssisted partner servicesCostHIVIntegrationKenyaMicrocosting

Identifiers

PMID35031037
PMCPMC8759219
OpenAlexW4206696763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.